Hsiao-Yen Ma
Research Subjects
Research Interests
Hsiao-Yen Ma has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Amanda J. Roberts
Animal Models Core Facility, The Scripps Research Institute, La Jolla, California, USA
1 shared publication - Bin Gao
Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
1 shared publication - Binhai Zheng
Department of Neurosciences, School of Medicine, University of California San Diego, La Jolla, USA
1 shared publication - Candice Contet
Department of Translational Medicine The Scripps Research Institute La Jolla California USA
1 shared publication Cedric G. Geoffroy
Department of Neurosciences, School of Medicine, UCSD, San Diego, California, USA
1 shared publication- Christopher K. Glass
Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA
1 shared publication
Latest Publications
- 13 February 2020
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (3)
Blockade of IL-17 signaling reverses alcohol-induced liver injury and excessive alcohol drinking in mice
Chronic alcohol abuse has a detrimental effect on the brain and liver. There is no effective treatment for these patients, and the mechanism underlying alcohol addiction and consequent alcohol-induced damage of the liver/brain axis remains unresolved. We compared experimental models of alcoholic liver disease (ALD) and alcohol dependence in mice and demonstrated that genetic ablation of IL-17 receptor A (IL-17ra –/– ) or pharmacological blockade of IL-17 signaling effectively suppressed the increased voluntary alcohol drinking in alcohol-dependent mice and blocked alcohol-induced hepatocellular and neurological damage. The level of circulating IL-17A positively correlated with the alcohol use in excessive drinkers and was further increased in patients with ALD as compared with healthy individuals. Our data suggest that IL-17A is a common mediator of excessive alcohol consumption and alcohol-induced liver/brain injury, and targeting IL-17A may provide a novel strategy for treatment of alcohol-induced pathology.
- 13 February 2020
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (3)
Blockade of IL-17 signaling reverses alcohol-induced liver injury and excessive alcohol drinking in mice
Chronic alcohol abuse has a detrimental effect on the brain and liver. There is no effective treatment for these patients, and the mechanism underlying alcohol addiction and consequent alcohol-induced damage of the liver/brain axis remains unresolved. We compared experimental models of alcoholic liver disease (ALD) and alcohol dependence in mice and demonstrated that genetic ablation of IL-17 receptor A (IL-17ra –/– ) or pharmacological blockade of IL-17 signaling effectively suppressed the increased voluntary alcohol drinking in alcohol-dependent mice and blocked alcohol-induced hepatocellular and neurological damage. The level of circulating IL-17A positively correlated with the alcohol use in excessive drinkers and was further increased in patients with ALD as compared with healthy individuals. Our data suggest that IL-17A is a common mediator of excessive alcohol consumption and alcohol-induced liver/brain injury, and targeting IL-17A may provide a novel strategy for treatment of alcohol-induced pathology.